Advertisement
AYTU vs DERM
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYTU is a StrongBuy and DERM is a Hold.
AYTU's RSI Indicator recovers from oversold territory
The RSI Indicator for AYTU moved out of oversold territory on October 13, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In 33 of the 36 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for AYTU just turned positive on October 29, 2026. Looking at past instances where AYTU's MACD turned positive, the stock continued to rise in 34 of 50 cases over the following month. The odds of a continued upward trend are 68%.
Following a +4.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where AYTU advanced for three days, in 169 of 229 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
AYTU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AYTU as a result. In 86 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AYTU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for AYTU entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.591) is normal, around the industry mean (7.659). P/E Ratio (-1.655) is within average values for comparable stocks, (0.330). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (0.320) is also within normal values, averaging (181.047).
The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. AYTU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AYTU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
DERM in -10.25% downward trend, falling for three consecutive days on November 03, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where DERM declined for three days, in 234 of 278 cases, the price declined further within the following month. The odds of a continued downward trend are 84%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DERM as a result. In 83 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The 50-day moving average for DERM moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Aroon Indicator for DERM entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where DERM's RSI Oscillator exited the oversold zone, 26 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for DERM just turned positive on October 29, 2026. Looking at past instances where DERM's MACD turned positive, the stock continued to rise in 47 of 53 cases over the following month. The odds of a continued upward trend are 89%.
Following a +9.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where DERM advanced for three days, in 232 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
DERM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.157) is normal, around the industry mean (7.659). P/E Ratio (-21.500) is within average values for comparable stocks, (0.330). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (2.865) is also within normal values, averaging (181.047).
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. DERM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DERM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
AYTU | DERM | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 12 | 60 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 24 Undervalued | 14 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 96 | |
PRICE GROWTH RATING 1..100 | 72 | 81 | |
P/E GROWTH RATING 1..100 | 33 | 16 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DERM's Valuation (14) in the Biotechnology industry is in the same range as AYTU (24) in the Other Consumer Services industry. This means that DERM’s stock grew similarly to AYTU’s over the last 12 months.
DERM's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AYTU (100) in the Other Consumer Services industry. This means that DERM’s stock grew similarly to AYTU’s over the last 12 months.
DERM's SMR Rating (96) in the Biotechnology industry is in the same range as AYTU (98) in the Other Consumer Services industry. This means that DERM’s stock grew similarly to AYTU’s over the last 12 months.
AYTU's Price Growth Rating (72) in the Other Consumer Services industry is in the same range as DERM (81) in the Biotechnology industry. This means that AYTU’s stock grew similarly to DERM’s over the last 12 months.
DERM's P/E Growth Rating (16) in the Biotechnology industry is in the same range as AYTU (33) in the Other Consumer Services industry. This means that DERM’s stock grew similarly to AYTU’s over the last 12 months.
| AYTU | DERM | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Stochastic ODDS (%) | 3 days ago 75% | 1 day ago 85% |
| Momentum ODDS (%) | 1 day ago 89% | 1 day ago 84% |
| MACD ODDS (%) | 1 day ago 68% | 1 day ago 89% |
| TrendWeek ODDS (%) | 1 day ago 86% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 86% | 1 day ago 82% |
| Advances ODDS (%) | 8 days ago 74% | 8 days ago 85% |
| Declines ODDS (%) | 18 days ago 85% | 3 days ago 84% |
| BollingerBands ODDS (%) | 1 day ago 84% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 89% | 1 day ago 83% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AYTU’s FA Score shows that 2 FA rating(s) are green while DERM’s FA Score has 2 green FA rating(s).
- AYTU’s FA Score: 2 green, 3 red.
- DERM’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AYTU’s TA Score shows that 5 TA indicator(s) are bullish while DERM’s TA Score has 5 bullish TA indicator(s).
- AYTU’s TA Score: 5 bullish, 3 bearish.
- DERM’s TA Score: 5 bullish, 4 bearish.
Price Growth
AYTU (@Pharmaceuticals: Generic) experienced а -2.54% price change this week, while DERM (@Pharmaceuticals: Generic) price change was -7.62% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.04%. For the same industry, the average monthly price growth was -6.45%, and the average quarterly price growth was +4.97%.
Reported Earning Dates
AYTU is expected to report earnings on Nov 12, 2026.
DERM is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-1.04% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
AYTU and
Correlation & Price change
A.I.dvisor tells us that AYTU and SIGA have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AYTU and SIGA's prices will move in lockstep.
| Ticker / NAME | Correlation To AYTU | 1D Price Change % | ||
|---|---|---|---|---|
| AYTU | 100% | -0.52% | ||
| SIGA - AYTU | 28% Poorly correlated | +1.29% | ||
| HROW - AYTU | 28% Poorly correlated | +0.74% | ||
| ZYBT - AYTU | 27% Poorly correlated | +2.24% | ||
| OGI - AYTU | 26% Poorly correlated | +5.37% | ||
| DERM - AYTU | 23% Poorly correlated | +1.94% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HEZU | 49.03 | 1.19 | +2.49% |
| iShares Currency Hedged MSCI Eurozone ETF (HEZU) | |||
| ACIO | 46.69 | 0.37 | +0.80% |
| Aptus Collared Investment Opportunity ETF (ACIO) | |||
| BAMV | 37.05 | 0.25 | +0.68% |
| Brookstone Value Stock ETF (BAMV) | |||
| VEMY | 27.38 | 0.14 | +0.51% |
| Virtus Stone Harbor Emerging Markets High Yield Bond ETF (VEMY) | |||
| LFAI | 142.38 | N/A | N/A |
| LifeX 2050 Longevity Income ETF (LFAI) | |||